Assenagon Asset Management S.A.
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1546007
SENNINGERBERG, N4
Position in TEVA
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$103,537,855
+$63,186,031 QoQ
Shares Held
3,056,017
+128.1% QoQ
Ownership
0.262%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#2
of 185 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $514,912,865 across 20 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (20.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
3,056,017 | $103,537,855 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
714,980 | $79,319,881 | |
| 3 | VTRS |
Viatris Inc
|
4,989,006 | $79,225,415 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,540,928 | $63,224,275 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
84,538 | $45,805,224 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
2,445,549 | $42,332,453 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
222,606 | $37,518,015 | |
| 8 | ZTS |
Zoetis Inc.
|
389,335 | $27,977,613 |
All Filings in TEVA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $103,537,855 | 3,056,017 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $40,351,824 | 1,339,702 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $67,811,465 | 2,172,748 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $168,232,791 | 8,328,356 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $141,554,825 | 8,445,992 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $91,972,973 | 5,983,928 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $25,559,369 | 1,159,681 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $25,045,042 | 1,389,847 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $6,565,032 | 404,002 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $14,825,362 | 1,050,699 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $6,050,627 | 579,562 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $734,338 | 71,994 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $13,857,255 | 1,840,273 | Shares | Sole | 2023-07-25 | |
| 2022-12-31 | $9,452,414 | 1,036,449 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $7,381,475 | 914,681 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $4,008,633 | 533,063 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $5,006,672 | 533,192 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $4,270,875 | 533,193 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $4,871,694 | 500,174 | Shares | Sole | 2021-10-19 | |
| No filing history on record for this holder in this stock. | ||||||